Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - victor+johnson
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Diisocyanate Specific Monoclonal Antibodies for Occupational and Environmental Monitoring of Polyurethane Production Exposure-related Asthma and Allergy and Clinical Diagnosis
CDC researchers have developed monoclonal antibodies useful as diagnostics for diisocyanate (dNCO) exposure and for toxicity characterization of specific dNCOs. Currently, dNCOs are used in the production of all polyurethane products and are the most commonly reported cause of occupational-induced asthma and also linked to allergic contact dermatitis....
Published: 10/28/2024
|
Inventor(s):
Donald Beezhold
,
Tinashe Ruwona
,
Detlef Schmechel
,
Victor Johnson
,
Paul Siegel
Keywords(s):
AAXXXX
,
AC5XXX
,
ACXXXX
,
AE2AXX
,
AE2CXX
,
AE2XXX
,
AE3XXX
,
AEXXXX
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
Compositions
,
CONJUGATES
,
IA2XXX
,
IA3XXX
,
IA5XXX
,
IAXXXX
,
IDXXXX
,
Isocyanate
,
IXXXXX
,
Methods
,
NIOSH-HELD
,
Relating
,
VPXXXX
,
WCXXXX
,
WFXXXX
,
WGXXXX
,
WIXXXX
,
WJXXXX
,
WMXXXX
,
XAXXXX
,
XCXXXX
,
XIXXXX
,
YAXXXX
,
YBXXXX
Category(s):
Collaboration Sought > Licensing
,
ResearchProducts > Antibodies
,
Application > Diagnostics
,
Application > Research Materials
,
Application > Occupational Safety and Health
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Immunology
,
TherapeuticArea > Oncology
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Endocrinology
,
TherapeuticArea > Dental
,
Application > Consumer Products
,
TherapeuticArea > Pulmonology
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Dermatology
Mitochondrial-Targeted Peptide Modulators of Delta Protein Kinase C Interaction with the d-subunit of F1Fo ATP Synthase/ATPase as Therapeutics Against Cardiac Injury
Current State of the Art: Current clinical therapy for heart attack victims focuses on the rapid restoration of blood flow by thrombolysis, angioplasty, stenting and when appropriate surgical coronary artery bypass grafts. Problems with the Current Art: The majority of cardiac cell death associated with a heart attack actually occurs during the...
Published: 4/29/2020
|
Inventor(s):
John Johnson
,
Tiffany Tuyen Nguyen
,
Mourad Ogbi
Keywords(s):
Cardiovascular
,
Heart Attack
,
Therapeutics
Category(s):
Therapeutics